Key result
Focused cardiac ultrasound detected LVH in 29.7% of ED patients with elevated blood pressure, with higher odds in women.
Why the study?
Early detection of target organ damage in hypertension is often missed, particularly in underserved populations. The prevalence of subclinical LVH and its differences by sex, race, and insurance status among ED patients with asymptomatic elevated blood pressure needed to be determined.
Does focused point-of-care cardiac ultrasound identify a significant prevalence of subclinical left ventricular hypertrophy in emergency department patients with asymptomatic elevated blood pressure?
Cross-Sectional (n=155)
No
Does focused point-of-care cardiac ultrasound identify a significant prevalence of subclinical left ventricular hypertrophy in emergency department patients with asymptomatic elevated blood pressure?
Answers are grounded in this paper and cite their sources.
Nearly one-third of emergency department patients presenting with asymptomatic elevated blood pressure had subclinical left ventricular hypertrophy on point-of-care ultrasound, with a significantly higher prevalence among women and presence even in 18.3% of those without a prior hypertension diagnosis.
Background Hypertension (HTN) is a leading cause of cardiovascular morbidity and mortality, yet early detection of target organ damage is often missed, particularly in patients with limited access to care. The Emergency Department (ED), a key site of care for underserved populations, may offer an opportunity for risk stratification; we sought to determine the prevalence of LVH—a marker of subclinical disease and increased cardiovascular risk—among ED patients with asymptomatic elevated blood pressure and assess differences by sex, race, and insurance status. Methods We enrolled a convenience sample of adults aged 18–65 years presenting to an academic ED with blood pressure ≥ 140 mmHg systolic or ≥ 90 mmHg diastolic on two measurements. Subjects with prior LVH, active cardiac disease, hypertensive emergency, dialysis dependence, or pregnancy were excluded. LVH was identified using left ventricular mass indexed to height 2.7 or body surface area via focused (point‐of‐care) cardiac ultrasound (parasternal long‐axis view). Multivariate logistic regression assessed associations with LVH. Results Among 155 subjects, 46 (29.7%, 95% CI 22.5%–36.9%) had LVH. Mean age was 46.9 ± 12.1 years; 53.6% were women. LVH was more prevalent in women (38.6% vs. 19.4%; p = 0.009) and remained independently associated with female sex (OR 2.44, 95% CI 1.14–5.22, p = 0.021) and prior hypertension (OR 2.47, 95% CI 1.14–5.39, p = 0.023). Notably, 18.3% of patients without a prior hypertension diagnosis demonstrated LVH ( p = 0.004). Conclusion Nearly one‐third of ED patients with elevated blood pressure had LVH, including many without known hypertension, with a higher prevalence among women. Trial Registration ClinicalTrials.gov identifier: NCT05730309
No takes yet. Share an insight, caveat, or question.
Baloescu et al. (2026) conducted a cross-sectional in Asymptomatic elevated blood pressure in the Emergency Department (n=155). Female sex (among patients with asymptomatic elevated blood pressure assessed via focused cardiac ultrasound) vs. Male sex was evaluated on Prevalence of subclinical left ventricular hypertrophy (LVH) identified via focused cardiac ultrasound (OR 2.44, 95% CI 1.14-5.22, p=0.021). Focused cardiac ultrasound detected LVH in 29.7% of ED patients with elevated blood pressure, with higher odds in women.
Synapse has enriched 10 related papers. Consider them for comparative context: